Literature DB >> 25056907

Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry.

Adriana Bora1, Ceereena Ubaida Mohien, Raghothama Chaerkady, Linda Chang, Richard Moxley, Ned Sacktor, Norman Haughey, Justin C McArthur, Robert Cotter, Avindra Nath, David R Graham.   

Abstract

We identified and measured proteins in the cerebral spinal fluid (CSF) involved in HIV-associated neurological disorders. Protein levels were determined by mass spectrometry (MS) in pooled CSF taken from three patient groups (human immunodeficiency virus (HIV)-1-infected patients that developed HIV-associated neurocognitive disorders (HANDs), HIV-1-infected patients without HAND, and healthy controls). Pools were generated from 10 patients each per group. CSF from individual patient groups were digested with trypsin and separately labeled using with isobaric tags for relative and absolute quantitation (iTRAQ). After combining all samples in one, peptides were extensively fractionated by offline two-dimensional separation and identified by tandem MS. One hundred and ninety three proteins were deemed to be interpretable for quantitation based on permutation tests with a 95 % confidence interval with a p value ≤ 0.05. Using a cutoff of 1.5-fold for upregulation and 0.6 for downregulation, 16 proteins were differentially expressed in HIV + HAND (reporter p value ≤0.05) with seven of them previously described as HIV-interacting proteins: endoplasmin, mitochondrial damage mediator-BH3-interacting domanin death agonist, orosomucoid, apolipoprotein E, metalloproteinase inhibitor 2, peroxiredoxin-2, and the nuclear protein, ruvB-like 2. Several previously unidentified proteins with possible neurological implication in HIV patients include forming-binding protein 1, C-reactive protein, leukocyte-associated immunoglobulin receptor 1, renin receptor, mediator of RNA polymerase II transcription subunit 14, multimerin-2, alpha-N-acetylglucosaminidase, caldesmon, and cadherin EGF LAG G-type receptor. Our results suggest that not only a few but possibly a combination of biomarkers that are highly correlated can predict neurocognitive status in HIV-infected patients and might be involved in monocyte or macrophage activation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056907      PMCID: PMC4493746          DOI: 10.1007/s13365-014-0263-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  58 in total

1.  HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation.

Authors:  Z Nie; B N Phenix; J J Lum; A Alam; D H Lynch; B Beckett; P H Krammer; R P Sekaly; A D Badley
Journal:  Cell Death Differ       Date:  2002-11       Impact factor: 15.828

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

3.  ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions.

Authors:  Philip B Verghese; Joseph M Castellano; Kanchan Garai; Yinong Wang; Hong Jiang; Aarti Shah; Guojun Bu; Carl Frieden; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-25       Impact factor: 11.205

4.  Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.

Authors:  Y Liu; M Jones; C M Hingtgen; G Bu; N Laribee; R E Tanzi; R D Moir; A Nath; J J He
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

5.  Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

Authors:  E Toschi; G Barillari; C Sgadari; I Bacigalupo; A Cereseto; D Carlei; C Palladino; C Zietz; P Leone; M Stürzl; S Buttò; A Cafaro; P Monini; B Ensoli
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

6.  Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages.

Authors:  A Atemezem; E Mbemba; R Vassy; H Slimani; L Saffar; L Gattegno
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

Review 7.  Oxidative stress and the HIV-infected brain proteome.

Authors:  Lerna Uzasci; Avindra Nath; Robert Cotter
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-09       Impact factor: 4.147

8.  Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.

Authors:  L Chico; C Simoncini; A Lo Gerfo; A Rocchi; L Petrozzi; C Carlesi; L Volpi; G Tognoni; G Siciliano; U Bonuccelli
Journal:  Free Radic Res       Date:  2013-06-19

9.  Peripheral inflammatory markers in amnestic mild cognitive impairment.

Authors:  Salman Karim; Steve Hopkins; Nitin Purandare; Jackie Crowther; Julie Morris; Pippa Tyrrell; Alistair Burns
Journal:  Int J Geriatr Psychiatry       Date:  2013-07-15       Impact factor: 3.485

Review 10.  Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection.

Authors:  Richard W Price; Julia Peterson; Dietmar Fuchs; Thomas E Angel; Henrik Zetterberg; Lars Hagberg; Serena Spudich; Richard D Smith; Jon M Jacobs; Joseph N Brown; Magnus Gisslen
Journal:  J Neuroimmune Pharmacol       Date:  2013-08-13       Impact factor: 4.147

View more
  12 in total

Review 1.  Childhood maltreatment and HIV-associated neurocognitive disorders share similar pathophysiology: a potential sensitisation mechanism?

Authors:  Jacqueline S Womersley; Soraya Seedat; Sian M J Hemmings
Journal:  Metab Brain Dis       Date:  2017-07-05       Impact factor: 3.584

2.  Mass spectrometric phosphoproteome analysis of HIV-infected brain reveals novel phosphorylation sites and differential phosphorylation patterns.

Authors:  Lerna Uzasci; Sungyoung Auh; Robert J Cotter; Avindra Nath
Journal:  Proteomics Clin Appl       Date:  2015-08-12       Impact factor: 3.494

3.  Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study.

Authors:  Leah H Rubin; Lorie Benning; Sheila M Keating; Philip J Norris; Jane Burke-Miller; Antonia Savarese; Krithika N Kumanan; Saria Awadalla; Gayle Springer; Kathyrn Anastos; Mary Young; Joel Milam; Victor G Valcour; Kathleen M Weber; Pauline M Maki
Journal:  J Neurovirol       Date:  2017-10-23       Impact factor: 2.643

Review 4.  Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era.

Authors:  Albert M Anderson; Qing Ma; Scott L Letendre; Jennifer Iudicello
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-15       Impact factor: 5.071

Review 5.  Investigating the biology of alpha herpesviruses with MS-based proteomics.

Authors:  Esteban A Engel; Ren Song; Orkide O Koyuncu; Lynn W Enquist
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

6.  Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection.

Authors:  Amanda Brown
Journal:  Clin Transl Med       Date:  2015-02-26

Review 7.  Proteomics, biomarkers, and HIV-1: A current perspective.

Authors:  Maire Rose Donnelly; Pawel Ciborowski
Journal:  Proteomics Clin Appl       Date:  2015-07-08       Impact factor: 3.494

Review 8.  HIV as a Cause of Immune Activation and Immunosenescence.

Authors:  T Sokoya; H C Steel; M Nieuwoudt; T M Rossouw
Journal:  Mediators Inflamm       Date:  2017-10-25       Impact factor: 4.711

9.  Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression.

Authors:  Matteo Basilissi; Camilla Tincati; Esther Merlini; Giuseppe Ancona; Elisa Borghi; Francesca Borgo; Alessandra Barassi; Antonella d'Arminio Monforte; Giulia Marchetti
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

10.  HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?

Authors:  Alessandra Bandera; Lucia Taramasso; Giorgio Bozzi; Antonio Muscatello; Jake A Robinson; Tricia H Burdo; Andrea Gori
Journal:  Front Aging Neurosci       Date:  2019-08-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.